Healing Blend 10/10mg

Performance Profile

• Dual-Peptide Research Matrix: BPC-157 and TB-500 pre-combined in one vial — allows researchers to study both tissue repair pathways simultaneously without managing two separate compounds.
• Multi-Tissue Coverage: Covers gastrointestinal, musculoskeletal, and connective tissue research pathways from a single preparation.
• Complementary Mechanisms: Each compound targets a distinct repair pathway — angiogenesis via BPC-157, cell migration via TB-500 — enabling broader pathway coverage per research session.

Quick Summary

• Best For: Multi-tissue repair research combining two well-documented compounds in a single preparation.
• Use Case: Studying how BPC-157 and TB-500’s complementary mechanisms interact when both pathways are active at the same time.
• Research Advantage: Reduces protocol complexity for combination pathway studies — two well-characterised compounds, one vial.

For research purposes only. Not for human consumption. For use by licensed researchers only. These compounds have not been evaluated or approved by Health Canada for human use.